Paxlovid May Reduce Risk of Long Covid in Eligible Patients, Study Finds
Health
By BY PAM BELLUCK from NYT Health https://ift.tt/spU5djc
via IFTTT Long Covid, Paxlovid (Drug), Coronavirus (2019-nCoV), Chronic Condition (Health), Research, Electronic Health Records, Veterans, Disease Rates The research looked at patients who qualified for the antiviral through age or health conditions. Those who took it shortly after infection were 26 percent less likely to have symptoms 90 days later.

By BY PAM BELLUCK from NYT Health https://ift.tt/spU5djc
via IFTTT Long Covid, Paxlovid (Drug), Coronavirus (2019-nCoV), Chronic Condition (Health), Research, Electronic Health Records, Veterans, Disease Rates The research looked at patients who qualified for the antiviral through age or health conditions. Those who took it shortly after infection were 26 percent less likely to have symptoms 90 days later.
Comments
Post a Comment